Ligand Pharmaceuticals Inc

NASDAQ:LGND

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LGND's stock price target?

Price Target

119.14 USD

According to Wall Street analysts, the average 1-year price target for LGND is 119.14 USD with a low forecast of 95.95 USD and a high forecast of 151.2 USD.

What is Ligand Pharmaceuticals Inc's Revenue forecast?

Projected CAGR

20%

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 20%.

What is Ligand Pharmaceuticals Inc's Operating Income forecast?

Projected CAGR

128%

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's operating income is -12%. The projected CAGR for the next 3 years is 128%.

What is Ligand Pharmaceuticals Inc's Net Income forecast?

Projected CAGR

38%

For the last 8 years the compound annual growth rate for Ligand Pharmaceuticals Inc's net income is -17%. The projected CAGR for the next 3 years is 38%.